Form 4: TransDigm Group INC: Co-Chief Operating Officer Joel Reiss Reports Stock Option Exercise and Sale
SEC Form 4
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on May 20, 2025, according to a Form 4 filing.
Summary
- On May 20, 2025, Joel Reiss, the Co-Chief Operating Officer of TransDigm Group INC, exercised stock options for 3,000 shares at a price of $284.97 per share.
- Following the exercise, Reiss sold a total of 3,000 shares of common stock in multiple transactions at prices ranging from $1,429.5633 to $1,436.6300.
- After these transactions, Reiss directly owns 3,600 shares of TransDigm Group INC common stock.
- Reiss also holds 62,000 derivative securities in the form of stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions. It doesn't indicate positive or negative outlook for the company.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are standard practice among publicly traded companies like TransDigm Group INC.
- Comparing the exercise price and sale price to those of executives at similar aerospace and defense companies (e.g., Boeing, Lockheed Martin) could provide context on the attractiveness of TransDigm's compensation structure.
- The timing and volume of stock sales can be compared to industry peers to assess whether the executive's actions are in line with typical behavior or indicative of a specific outlook on the company's performance.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market.
- The transaction provides insight into the executive's personal financial decisions, which can be of interest to stakeholders.
Key Dates
| Date | Description |
|---|---|
| 09/30/2021 | Date exercisable for stock options |
| 11/08/2027 | Expiration date for stock options |
| 05/20/2025 | Date of stock option exercise and share sales |
Keywords
TransDigm Group INC, Joel Reiss, Stock Options, Form 4, Share Sale, Executive Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.